Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 11;12(3):557.
doi: 10.3390/antibiotics12030557.

Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections

Matthew S Linz  1 , Arun Mattappallil  2 , Diana Finkel  3 , Dane Parker  1
Affiliations
Review

Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections

Matthew S Linz et al. Antibiotics (Basel). .

Abstract

The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused by the epidemic clone USA300 in the USA. These infections can be serious; in 2019, SSTIs with S. aureus were associated with an all-cause, age-standardized mortality rate of 0.5 globally. Clinical presentations of S. aureus SSTIs vary from superficial infections with local symptoms to monomicrobial necrotizing fasciitis, which can cause systemic manifestations and may lead to serious complications or death. In order to cause skin infections, S. aureus employs a host of virulence factors including cytolytic proteins, superantigenic factors, cell wall-anchored proteins, and molecules used for immune evasion. The immune response to S. aureus SSTIs involves initial responders such as keratinocytes and neutrophils, which are supported by dendritic cells and T-lymphocytes later during infection. Treatment for S. aureus SSTIs is usually oral therapy, with parenteral therapy reserved for severe presentations; it ranges from cephalosporins and penicillin agents such as oxacillin, which is generally used for methicillin-sensitive S. aureus (MSSA), to vancomycin for methicillin-resistant S. aureus (MRSA). Treatment challenges include adverse effects, risk for Clostridioides difficile infection, and potential for antibiotic resistance.

Keywords: Staphylococcus aureus; antibiotics; antimicrobial resistance; bacterial pathogenesis; clinical presentation; epidemiology; skin-and-soft-tissue infections; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Major virulence factors involved in S. aureus SSTIs and some of their associated mechanisms.
See this image and copyright information in PMC

References

    1. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., Nouwen J.L. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005;5:751–762. doi: 10.1016/S1473-3099(05)70295-4. - DOI - PubMed
    1. Grundmann H., Aires-De-Sousa M., Boyce J., Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874–885. doi: 10.1016/S0140-6736(06)68853-3. - DOI - PubMed
    1. Tenover F.C., McDougal L.K., Goering R.V., Killgore G., Projan S.J., Patel J.B., Dunman P.M. Characterization of a Strain of Community-Associated Methicillin-Resistant Staphylococcus aureus Widely Disseminated in the United States. J. Clin. Microbiol. 2006;44:108–118. doi: 10.1128/JCM.44.1.108-118.2006. - DOI - PMC - PubMed
    1. De Leo F.R., Kennedy A.D., Chen L., Wardenburg J.B., Kobayashi S.D., Mathema B., Braughton K.R., Whitney A.R., Villaruz A.E., Martens C.A., et al. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc. Natl. Acad. Sci. USA. 2011;108:18091–18096. doi: 10.1073/pnas.1111084108. - DOI - PMC - PubMed
    1. Turner N.A., Sharma-Kuinkel B.K., Maskarinec S.A., Eichenberger E.M., Shah P.P., Carugati M., Holland T.L., Fowler V.G., Jr. Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat. Rev. Microbiol. 2019;17:203–218. doi: 10.1038/s41579-018-0147-4. - DOI - PMC - PubMed

LinkOut - more resources